205 related articles for article (PubMed ID: 17942478)
1. Cloning, characterization and site-directed mutagenesis of canine renin.
Bukhtiyarov Y; Zecher M; Panemangalore R; Wu Z; Bruno JG; Yuan J; Xu Z; Dillard LW; McGeehan GM; Harrison RK; Scott BB
J Biochem; 2007 Dec; 142(6):671-80. PubMed ID: 17942478
[TBL] [Abstract][Full Text] [Related]
2. The His-Pro-Phe motif of angiotensinogen is a crucial determinant of the substrate specificity of renin.
Nakagawa T; Akaki J; Satou R; Takaya M; Iwata H; Katsurada A; Nishiuchi K; Ohmura Y; Suzuki F; Nakamura Y
Biol Chem; 2007 Feb; 388(2):237-46. PubMed ID: 17261087
[TBL] [Abstract][Full Text] [Related]
3. Purification and characterization of recombinant human cathepsin E expressed in human kidney cell line 293.
Cappiello MG; Wu Z; Scott BB; McGeehan GM; Harrison RK
Protein Expr Purif; 2004 Sep; 37(1):53-60. PubMed ID: 15294281
[TBL] [Abstract][Full Text] [Related]
4. The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: studies with molecular chimeras.
Suzuki F; Nakagawa T; Kakidachi H; Murakami K; Inagami T; Nakamura Y
Biochem Biophys Res Commun; 2000 Jan; 267(2):577-80. PubMed ID: 10631104
[TBL] [Abstract][Full Text] [Related]
5. Highly sensitive intramolecularly quenched fluorogenic substrates for renin based on the combination of L-2-amino-3-(7-methoxy-4-coumaryl)propionic acid with 2,4-dinitrophenyl groups at various positions.
Paschalidou K; Neumann U; Gerhartz B; Tzougraki C
Biochem J; 2004 Sep; 382(Pt 3):1031-8. PubMed ID: 15233625
[TBL] [Abstract][Full Text] [Related]
6. Recombinant human renin produced in different expression systems: biochemical properties and 3D structure.
Mathews S; Döbeli H; Pruschy M; Bosser R; D'Arcy A; Oefner C; Zulauf M; Gentz R; Breu V; Matile H; Schlaeger J; Fischli W
Protein Expr Purif; 1996 Feb; 7(1):81-91. PubMed ID: 9172787
[TBL] [Abstract][Full Text] [Related]
7. Peptide inhibitors of renin in cardiovascular studies.
Haber E
Fed Proc; 1983 Dec; 42(15):3155-61. PubMed ID: 6196232
[TBL] [Abstract][Full Text] [Related]
8. Stable expression, secretion, and characterization of active human renin in mammalian cells.
Norman JA; Hadjilambris O; Baska R; Sharp DY; Kumar R
Mol Pharmacol; 1992 Jan; 41(1):53-9. PubMed ID: 1732722
[TBL] [Abstract][Full Text] [Related]
9. Substrate specificity and inhibitor structure-activity relationships of recombinant human renin: implications in the in vivo evaluation of renin inhibitors.
Evans DB; Cornette JC; Sawyer TK; Staples DJ; de Vaux AE; Sharma SK
Biotechnol Appl Biochem; 1990 Apr; 12(2):161-75. PubMed ID: 2184838
[TBL] [Abstract][Full Text] [Related]
10. The first Sir George Pickering memorial lecture. Which inhibitors will give us true insight into what renin really does?
Haber E
J Hypertens; 1984 Jun; 2(3):223-30. PubMed ID: 6099385
[TBL] [Abstract][Full Text] [Related]
11. A continuous fluorescence assay of renin activity.
Wang GT; Chung CC; Holzman TF; Krafft GA
Anal Biochem; 1993 May; 210(2):351-9. PubMed ID: 8512070
[TBL] [Abstract][Full Text] [Related]
12. Porcine germinal angiotensin I-converting enzyme: isolation, characterization and molecular cloning.
Takeuchi K; Araki H; Sakaue T; Yamamoto Y; Fujiwara M; Nishi K; Ohkubo I
Comp Biochem Physiol B Biochem Mol Biol; 2007 Feb; 146(2):215-26. PubMed ID: 17145192
[TBL] [Abstract][Full Text] [Related]
13. Renin cleavage of a human kidney renin substrate analogous to human angiotensinogen, H-Asp-Arg-Val-Tyr-Ile-His-Pro-Phe-His-Leu-Val-Ile-His-Ser-OH, that is human renin specific and is resistant to cathepsin D.
Poe M; Wu JK; Lin TY; Hoogsteen K; Bull HG; Slater EE
Anal Biochem; 1984 Aug; 140(2):459-67. PubMed ID: 6385771
[TBL] [Abstract][Full Text] [Related]
14. Will renin inhibitors influence decision-making in antihypertensive therapy?
Haber E
J Hypertens Suppl; 1985 Nov; 3(2):S71-80. PubMed ID: 3003303
[TBL] [Abstract][Full Text] [Related]
15. Renin: structural features of active enzyme and inactive precursor.
Inagami T; Chang JJ; Dykes CW; Takii Y; Kisaragi M; Misono KS
Fed Proc; 1983 Jul; 42(10):2729-34. PubMed ID: 6407871
[TBL] [Abstract][Full Text] [Related]
16. Proton inventory studies of alpha-thrombin-catalyzed reactions of substrates with selected P and P' sites.
Enyedy EJ; Kovach IM
J Am Chem Soc; 2004 May; 126(19):6017-24. PubMed ID: 15137766
[TBL] [Abstract][Full Text] [Related]
17. The role of Tyr605 and Ala607 of thimet oligopeptidase and Tyr606 and Gly608 of neurolysin in substrate hydrolysis and inhibitor binding.
Machado MF; Rioli V; Dalio FM; Castro LM; Juliano MA; Tersariol IL; Ferro ES; Juliano L; Oliveira V
Biochem J; 2007 Jun; 404(2):279-88. PubMed ID: 17313369
[TBL] [Abstract][Full Text] [Related]
18. Acid-activatable inactive renin in cat plasma and kidney.
Glorioso N; Troffa C; Atlas SA; Sealey JE
J Hypertens Suppl; 1986 Dec; 4(5):S6-9. PubMed ID: 3553486
[TBL] [Abstract][Full Text] [Related]
19. Baculoviral expression and characterization of rodent cathepsin S.
Mason CS; Lamers MB; Henderson IM; Monk T; Williams DH
Protein Expr Purif; 2001 Oct; 23(1):45-54. PubMed ID: 11570845
[TBL] [Abstract][Full Text] [Related]
20. Site-directed mutagenesis of human prorenin. Substitution of three arginine residues in the propeptide with glutamine residues yields active prorenin.
Yamauchi T; Nagahama M; Watanabe T; Ishizuka Y; Hori H; Murakami K
J Biochem; 1990 Jan; 107(1):27-31. PubMed ID: 2185237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
